Clinical Trials in New York

Showing 10721-10740 of 19,464 trials

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

NCT04009083

This is a prospective outcomes study assessing quality of life and oncological control at pre-defined time points following FOCAL CRYO-ABLATION (FCA). The investigator's standard of care is to perform an Magentic Resonance Imaging (MRI) and prostate biopsy two years following FCA. The prostate biopsy assesses both the presence of in field and out of field disease. The role of Axumin PET/MRI for detecting disease following FCA has not been previously examined.

Prostate Cancer

NYU Langone Health31 participantsStarted Jun 2019

New York, New York, United States

COMPLETEDPhase 4< 1 mile

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

NCT00139776

To determine whether "continuous use" of celecoxib over a 6-month period is more efficacious than "usual or intermittent use" in preventing spontaneous osteoarthritis flares of the knee and hip.

Osteoarthritis, KneeOsteoarthritis, Hip

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.875 participantsStarted Jul 2005

Huntsville, Alabama, United States • Peoria, Arizona, United States • Phoenix, Arizona, United States +121 more locations

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Find Trials by Condition in New York

GLORIA-AF Registry Program - Second and Third Phases

Ketamine Infusion as Sedative Analgesic in Severe ARDS

The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Eliminating Hepatitis C Virus

IBUPAP Study for Pain Management in Children

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

The Diet Gout Trial

IN.PACT Global Clinical Study

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children